Status:
NOT_YET_RECRUITING
Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype
Lead Sponsor:
Pierre Fabre Dermo Cosmetique
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Brief Summary
In this study, we assess the efficacy of a cosmetic product in adults with IV to VI skin phototype. This study is conducted as a monocentric, controlled, compared with an untreated area and randomize...
Eligibility Criteria
Inclusion
- Main inclusion criteria :
- Man or woman from 18 to 50 years old
- Phototype IV to VI according to the Fitzpatrick classification
- Subject smoking ≤ 10 cigarettes/day containing nicotine, paper or e-cigarette equivalent
- Subject agreeing not to expose his forearms to UV (natural or artificial) throughout the duration of the study and up to 3 months after the end of participation in the study
- Subject protected by a tetanus vaccination according to the vaccination schedule established by the Public Health Agency
- Main non-inclusion criteria:
- Subject suffering from a disease liable to affect the wound healing process according to the opinion of the investigator
- Subject with a known history of allergy or contact dermatitis induced in particular by the latex, the plaster, the local anesthetic, the local antiseptic or one of the components of the study product
- Subject with a disease including skin disease in progress on the upper limbs that may interfere with the interpretation of the evaluation criteria according to the opinion of the investigator
- Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational product according to the investigator's assessment
Exclusion
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 5 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT07166484
Start Date
September 15 2025
End Date
December 5 2025
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Research Center
Toulouse, France, France, 31000